‘We’re increasingly seeing incidents where alert fatigue has been identified as a contributing factor. It’s not that there wasn’t an alert in place, but that it was lost among the other alerts the clinician saw,’ Prof Baysari says.
The pain of uncertainty: Managing pain without codeine
With over-the-counter (OTC) codeine products being upscheduled, pharmacists and pharmacy staff need to review and understand every patient’s pain. In doing so, there’s an...
National Diabetes Week: now is the time to help people stay...
ADVERTORIAL BY GLUCERNA®
It can be challenging for those with impaired glucose tolerance or insulin resistance to maintain a healthy, low GI diet; especially considering...
An innovative, effective OTC solution to scalp pruritus
Dermal Therapy’s Scalp Relief range is clinically proven to relieve scalp itch and irritation in minutes. It is steroid- and tar-free and targets multiple common causes of itchy scalp.
Nasal swab offers hope for reducing vancomycin use
A study has found a pharmacy-driven protocol using nasal swabs to assess methicillin‑resistant Staphylococcus aureus (MRSA) in pneumonia cases holds promise for reducing unnecessary...
A simple way to improve pharmacist-patient interactions
Checking technicians would allow pharmacists to spend more time on patient-focused activities in both community and hospital pharmacy settings, New Zealand research has found.
Based...
Efficacy of antiplatelets in deep venous thrombosis
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
